Funding for this research was provided by:
Global Fund to Fight AIDS, Tuberculosis and Malaria (TB-REP 2.0, TB-REP 2.0, TB-REP 2.0, TB-REP 2.0, TB-REP 2.0, TB-REP 2.0)
Received: 9 May 2022
Accepted: 21 October 2022
First Online: 1 November 2022
: Authors confirm that all methods were carried out in accordance with relevant guidelines and regulations or Declaration of Helsinki.
: Ethics committees that approved the study and the committee’s reference numbers are:
: Georgia: Institutional Review Board for National Center for Disease Control and Public Health / IRB 00002150;
: Kazakhstan: Local Ethical Commission of the Asfendiyarov Kazakh National Medical University.
: Tajikistan: Committee for Biomedical Ethics, Ministry of Health and Social Protection, Tajikistan, Academy of Medical Sciences.
: The Republic of Moldova: National Committee for Ethical Expertise of Clinical trial, Ministry of Health, Labor and Social Protection of the Republic of Moldova.
: Not applicable.
: Informed consent was obtained from all subjects involved in the study.
: The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.